Comparative Phase 3 Trial to Assess the Safety and Efficacy of Triple-chamber Parenteral Nutrition Formulation

NCT ID: NCT01579097


Title
A Randomized, Comparative Phase 3 Trial to Assess the Safety and Efficacy of Triple-Chamber Parenteral Nutrition Formulation (Oliclinomel N4)
Purpose
The objective of this study is to assess the safety and efficacy of Oliclinomel N4 compared to compounded ternary parenteral nutrition (PN) admixtures for the delivery of PN in hospitalized adults for whom oral or enteral nutrition is not possible, insufficient, or contraindicated.
Details
Conditions
Nutrition Support
Keywords
(PN) Parenteral nutrition, oral/enteral not possible
Source
Baxter Healthcare Corporation
Sponsors
Baxter Healthcare Corporation
Status
Completed
Acronym
Last Updated
30 Jan 2013
URL
Official Link
Locations
China